Chen Bihua
Transaction: 07/01/2026
SELL
Change
-4,528,186
Price
Not reported
Filing
07/06/2026
Type
SELL
BridgeBio Oncology Therapeutics Inc.
BBOT • Biotechnology
$8.98
▲ +0.08 (+0.90%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$718.88M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 12.14Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:10 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$8.98
Change0.90%
Shares Out80.05M
Market Cap$718.88M
Enterprise Value$495.69M
52W Range7.00 - 14.87
Beta0.36
P/E-3.95
P/B2.22
P/FCF-3.71
EV/EBITDA-2.50
EV/FCF-2.56
Price$8.98
Change0.90%
Shares Out80.05M
Market Cap$718.88M
Enterprise Value$495.69M
52W Range7.00 - 14.87
Beta0.36
P/E-3.95
P/B2.22
P/FCF-3.71
EV/EBITDA-2.50
EV/FCF-2.56
Earnings Yield-25.33%
FCF Yield-26.96%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio12.14
Quick Ratio12.14
Target$23.00
Target Upside156.12%
Target Median$23.00
Target Range23.00 - 23.00
Volume142.49K
Avg Volume422.40K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 12.14Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
100/100
Bullish
Bullish
4
Hold
0
Bearish
0
Price Target
2026-08-13
Low
$23.00
Mean
$23.00
Median
$23.00
High
$23.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Beltran Pedro
Transaction: 07/01/2026
SELL
Change
-1,047
Price
$7.80
Filing
07/06/2026
Type
SELL
Ben Yong
Transaction: 07/01/2026
SELL
Change
-1,047
Price
$7.80
Filing
07/06/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Chen Bihua | SELL | -4,528,186 | Not reported | 07/01/2026 | 07/06/2026 |
| Beltran Pedro | SELL | -1,047 | $7.80 | 07/01/2026 | 07/06/2026 |
| Ben Yong | SELL | -1,047 | $7.80 | 07/01/2026 | 07/06/2026 |
| Elmelech Idan | SELL | -343 | $7.80 | 07/01/2026 | 07/06/2026 |
| Cobo Marc | SELL | -125 | $7.80 | 07/01/2026 | 07/06/2026 |
| Kumar Neil | BUY | +31,675 | $7.73 | 06/16/2026 | 06/18/2026 |
| Bauer Jake | BUY | +31,675 | $7.73 | 06/16/2026 | 06/18/2026 |
| Chen Bihua | BUY | +31,675 | $7.73 | 06/16/2026 | 06/18/2026 |
| Kelleher Raymond J. | BUY | +31,675 | $7.73 | 06/16/2026 | 06/18/2026 |
| Lebowitz Peter F | BUY | +7,289 | $7.73 | 06/16/2026 | 06/18/2026 |
| MCCORMICK FRANK | BUY | +31,675 | $7.73 | 06/16/2026 | 06/18/2026 |
| Tipirneni Praveen P. | BUY | +31,675 | $7.73 | 06/16/2026 | 06/18/2026 |
| Beltran Pedro | BUY | +1,103,837 | $7.66 | 05/10/2026 | 05/12/2026 |
| Elmelech Idan | BUY | +758,222 | $7.66 | 05/10/2026 | 05/12/2026 |
| Mehra Uneek | SELL | -524 | $9.03 | 04/01/2026 | 05/05/2026 |
| Beltran Pedro | SELL | -1,047 | $9.03 | 04/01/2026 | 05/05/2026 |
| Ben Yong | SELL | -1,047 | $9.03 | 04/01/2026 | 05/05/2026 |
| Cobo Marc | OTHER | +25,125 | $10.19 | 04/21/2026 | 04/30/2026 |
| Cobo Marc | OTHER | 0 | Not reported | 04/21/2026 | 04/30/2026 |
| Elmelech Idan | OTHER | +68,310 | $10.19 | 04/20/2026 | 04/30/2026 |